Cleared Traditional

K122787 - COMFORT EZ

K122787 is an FDA 510(k) clearance for COMFORT EZ, manufactured by Simple Diagnostics, Inc.. The device is a Class 2 General Hospital device with product code FMF cleared through the Traditional 510(k) pathway after a 86-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2012
Decision
86d
Days
Class 2
Risk

K122787 is an FDA 510(k) clearance for the COMFORT EZ. Classified as Syringe, Piston (product code FMF), Class II - Special Controls.

Submitted by Simple Diagnostics, Inc. (Naples, US). The FDA issued a Cleared decision on December 6, 2012 after a review of 86 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5860 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Simple Diagnostics, Inc. devices

FDA 510(k) Submission Details - K122787

510(k) Number K122787 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 11, 2012
Decision Date December 06, 2012
Days to Decision 86 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
43d faster than avg
Panel avg: 129d · This submission: 86d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMF Device Classification - Class 2, Special Controls

Product Code FMF Syringe, Piston
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMF Syringe, Piston

All 516
Devices cleared under the same product code (FMF) and FDA review panel - the closest regulatory comparables to K122787.
ARTIGLASS L. O.R. GLASS SYRINGE
K122416 · Artiglass Srl · May 2013
INTRADERMAL ADAPTER
K123588 · West Pharmaceutical Services, Inc. · Feb 2013
MONOJECT 12ML SYRINGE
K130049 · Nipro Medical Corporation · Feb 2013
REGEN SPRAY APPLICATOR,
K122122 · Regen Lab SA · Nov 2012
MIXJECT WITH SPRAY HEAD
K122023 · Medimop Medical Projects, Ltd. · Oct 2012
NEOMED ORAL/ENTERAL SYRINGE
K122373 · Neomed, Inc. · Sep 2012